Your Article Summary
Inspire Announces Pricing of $100 Million Common Stock Offering
Inspire, 08/07/09
Inspire Pharmaceuticals, Inc. announced the pricing of its previously announced public offering of its common stock at a price to the public of $4.50 per share and an increase in the offering size to 22.2 million shares. Inspire has granted Deutsche Bank Securities Inc., the sole underwriter of the offering, an option to purchase up to an additional 3.3 million shares of common stock to cover over–allotments, if any. All of the shares in the offering are being offered by Inspire. Inspire expects the offering to close on August 2009.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09
A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Article Search
Sponsor


See Latest Articles


